These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15720806)

  • 1. Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer.
    Gao J; Arbman G; Rearden A; Sun XF
    Neoplasia; 2004; 6(6):796-801. PubMed ID: 15720806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of PINCH in the stroma of oral squamous cell carcinoma predicts nodal metastasis.
    Zhang JT; Li QX; Wang D; Zhu ZL; Yang YH; Cui DS; Wang MW; Sun XF
    Oncol Rep; 2005 Dec; 14(6):1519-22. PubMed ID: 16273248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal myofibroblasts predict disease recurrence for colorectal cancer.
    Tsujino T; Seshimo I; Yamamoto H; Ngan CY; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2007 Apr; 13(7):2082-90. PubMed ID: 17404090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
    Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
    Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance.
    Nishihara K; Shomori K; Fujioka S; Tokuyasu N; Inaba A; Osaki M; Ogawa T; Ito H
    Int J Oncol; 2008 Aug; 33(2):245-51. PubMed ID: 18636144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PINCH protein in gliomas and its clinicopathological significance.
    Wang MW; Gu P; Zhang ZY; Zhu ZL; Li YM; Zhao HX; Sun XF
    Oncology; 2007; 72(5-6):343-6. PubMed ID: 18187956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
    Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
    Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.
    Moparthi SB; Arbman G; Wallin A; Kayed H; Kleeff J; Zentgraf H; Sun XF
    Int J Oncol; 2007 Jan; 30(1):91-5. PubMed ID: 17143516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of fibroblast activation protein in patients with colon cancer.
    Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
    Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.